-
Founded in:
2002-03-04 -
Country:
China -
Address:
No. 33, Hansha Street, Guanyinzhai Town, Shashi District, Jingzhou City, Hubei Province -
Tax NO.:
9142100018186208XQ -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clarithromycin |
This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.
More
This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect. |
81103-11-9 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Astragali Radix |
Not yet clear
More
Not yet clear |
0 | ||
| SAPOSHNIKOVIAE RADIX |
Not yet clear
More
Not yet clear |
0 | ||
| Atractylodes macrocephala (fried) |
Not yet clear
More
Not yet clear |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects
More
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects |
0.15g | 103-90-2 | 68 |
| Tween 80 |
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects. |
9005-65-6 | 17 | |
| Fatty acid glyceride,mixed |
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-(-)-Tartaric Acid |
It can significantly reduce the number of coughs caused by ammonia in guinea pigs (P<0.01) and significantly increase the tracheal phenol red excretion in mice (P<0.01), but no obvious antiasthmatic effect was found.
More
It can significantly reduce the number of coughs caused by ammonia in guinea pigs (P<0.01) and significantly increase the tracheal phenol red excretion in mice (P<0.01), but no obvious antiasthmatic effect was found. |
147-71-7 | 1 | |
| FRITILLARIAE USSURIENSIS BULBUS |
It can significantly reduce the number of coughs caused by ammonia in guinea pigs (P<0.01) and significantly increase the tracheal phenol red excretion in mice (P<0.01), but no obvious antiasthmatic effect was found.
More
It can significantly reduce the number of coughs caused by ammonia in guinea pigs (P<0.01) and significantly increase the tracheal phenol red excretion in mice (P<0.01), but no obvious antiasthmatic effect was found. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lithium |
Not yet clear
More
Not yet clear |
0 |